» Articles » PMID: 34503559

Anxiety and Depression in School-age Patients with Spinal Muscular Atrophy: a Cross-sectional Study

Overview
Publisher Biomed Central
Specialty General Medicine
Date 2021 Sep 10
PMID 34503559
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Spinal muscular atrophy (SMA) is a rare neurogenetic disease which involves multisystem dysfunctions such as respiratory, digestive, and motor disorders. Anxiety, depression and other psychological disorders often accompany severe chronic physical diseases. The aim of this study was to investigate the prevalence of anxiety and depression along with their influencing factors among school-age patients with SMA.

Methods: We conducted a cross-sectional study on school-age SMA patients in China. Patients aged 8-18 years with a genetic diagnosis of 5qSMA were invited to answer a questionnaire composed of sociodemographic and clinical questions, then to complete the Screen for Child Anxiety-Related Emotional Disorders and Depression Self-Rating Scale for depression and anxiety level evaluation. At the end of the questionnaire, further questions assessed the subjective anxiety and subjective depression of patients' caregivers and their expectations for their child's future.

Results: Complete data were available for 155 patients. The sample included 45.8% boys and 54.2% girls; 65.2% were type II, 27.1% were type III, and the remainder were type I SMA. Rates of anxiety and depression in these school-age SMA patients were 40.0% and 25.2%, respectively. Gender, age, and disease type were not associated with anxiety or depression, but respiratory system dysfunction, digestive system dysfunction, skeletal deformity, rehabilitation exercise, academic delay, specialized support from school, household income level, caregivers' subjective anxiety, and caregivers' expectations were significantly related to both anxiety and depression.

Conclusions: There was a high prevalence of anxiety and depression in school-age SMA patients in China. Professional psychological care maybe included in the standard of care. These results also call for possible targets for intervention such as reducing complications, improving drug accessibility, retaining normal schooling, strengthening school support, and enhancing the ability of the caregivers of SMA patients to assist in the diagnosis and treatment of the disease, so improving the mental health of SMA patients.

Citing Articles

Health-related quality of life of adults with spinal muscular atrophy: insights from a nationwide patient registry in Germany.

Landfeldt E, Leibrock B, Hussong J, Thiele S, Walter M, Moehler E Qual Life Res. 2024; 33(7):1949-1959.

PMID: 38753126 DOI: 10.1007/s11136-024-03665-5.


The socioeconomic burden of spinal muscular atrophy in Saudi Arabia: a cross-sectional pilot study.

Alotaibi K, Alsuhaibani M, Al-Essa K, Bamaga A, Mukhtar A, Alrumaih A Front Public Health. 2024; 12:1303475.

PMID: 38362212 PMC: 10867838. DOI: 10.3389/fpubh.2024.1303475.


Cognitive impairment in Chinese adult patients with type III spinal muscular atrophy without disease-modifying treatment.

Hu Y, Wei L, Li A, Liu T, Jiang Y, Xie C Front Neurol. 2023; 14:1226043.

PMID: 38020636 PMC: 10655145. DOI: 10.3389/fneur.2023.1226043.


Spinal Muscular Atrophy: An Evolving Scenario through New Perspectives in Diagnosis and Advances in Therapies.

Angilletta I, Ferrante R, Giansante R, Lombardi L, Babore A, DellElice A Int J Mol Sci. 2023; 24(19).

PMID: 37834320 PMC: 10573646. DOI: 10.3390/ijms241914873.


Serotonergic dysfunction impairs locomotor coordination in spinal muscular atrophy.

Delestree N, Semizoglou E, Pagiazitis J, Vukojicic A, Drobac E, Paushkin V Brain. 2023; 146(11):4574-4593.

PMID: 37678880 PMC: 10629775. DOI: 10.1093/brain/awad221.


References
1.
Schuch F, Stubbs B, Meyer J, Heissel A, Zech P, Vancampfort D . Physical activity protects from incident anxiety: A meta-analysis of prospective cohort studies. Depress Anxiety. 2019; 36(9):846-858. DOI: 10.1002/da.22915. View

2.
Chang T, Chen Y, Chang M, Lin C . Is there a close association of depression with either constipation or dysosmia in Parkinson's disease?. Sci Rep. 2020; 10(1):15476. PMC: 7511293. DOI: 10.1038/s41598-020-72381-0. View

3.
Vahter L, Braschinsky M, Haldre S, Gross-Paju K . The prevalence of depression in hereditary spastic paraplegia. Clin Rehabil. 2009; 23(9):857-61. DOI: 10.1177/0269215509337186. View

4.
Henning M, Subic-Wrana C, Wiltink J, Beutel M . Anxiety Disorders in Patients With Somatic Diseases. Psychosom Med. 2020; 82(3):287-295. DOI: 10.1097/PSY.0000000000000779. View

5.
Kessler R, Berglund P, Demler O, Jin R, Merikangas K, Walters E . Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005; 62(6):593-602. DOI: 10.1001/archpsyc.62.6.593. View